Allyson M. Pishko

1.1k total citations
34 papers, 427 citations indexed

About

Allyson M. Pishko is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Allyson M. Pishko has authored 34 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 12 papers in Surgery and 10 papers in Genetics. Recurrent topics in Allyson M. Pishko's work include Heparin-Induced Thrombocytopenia and Thrombosis (9 papers), Platelet Disorders and Treatments (9 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Allyson M. Pishko is often cited by papers focused on Heparin-Induced Thrombocytopenia and Thrombosis (9 papers), Platelet Disorders and Treatments (9 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Allyson M. Pishko collaborates with scholars based in United States, Canada and Australia. Allyson M. Pishko's co-authors include Adam Cuker, Douglas B. Cines, Lisa D. Levine, Sunita D. Nasta, Bhavya S. Doshi, Phyllis A. Gimotty, Gowthami M. Arepally, Mark Crowther, Koosha Paydary and Lawrence Rice and has published in prestigious journals such as New England Journal of Medicine, JAMA and Blood.

In The Last Decade

Allyson M. Pishko

27 papers receiving 422 citations

Peers

Countries citing papers authored by Allyson M. Pishko

Since Specialization

Citations

This map shows the geographic impact of Allyson M. Pishko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allyson M. Pishko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allyson M. Pishko more than expected).

Fields of papers citing papers by Allyson M. Pishko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allyson M. Pishko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allyson M. Pishko. The network helps show where Allyson M. Pishko may publish in the future.

Co-authorship network of co-authors of Allyson M. Pishko

This figure shows the co-authorship network connecting the top 25 collaborators of Allyson M. Pishko. A scholar is included among the top collaborators of Allyson M. Pishko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allyson M. Pishko. Allyson M. Pishko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pomalidomide for hereditary hemorrhagic telangiectasia: after trial longitudinal assessment study (PATH-HHT ATLAS) 2026 ·Blood Advances ·Elric Zhang, (unknown), Joseph G. Parambil, (unknown), (unknown), (unknown), (unknown), Allyson M. Pishko, Miles Conrad, (unknown), Josanna Rodriguez‐Lopez, (unknown), Hanny Al‐Samkari	0
2	Progressive silent cerebral infarction is associated with stroke and persistent cognitive impairment in survivors of iTTP 2025 ·Blood Advances ·Jia Yu, (unknown), (unknown), Gloria F. Gerber, Michael B. Streiff, Peggy S. Kraus, Samuel A. Merrill, Allyson M. Pishko, Jennifer Yui, Rakhi P. Naik, Robert A. Brodsky, Doris Lin, Shruti Chaturvedi	0
3	Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale 2025 ·Journal of Thrombosis and Haemostasis ·Hanny Al‐Samkari, Raj S. Kasthuri, Vivek Iyer, Allyson M. Pishko, (unknown), Clifford R. Weiss, Kevin J. Whitehead, Miles Conrad, Marc Zumberg, (unknown), Joseph G. Parambil, Benjamin Carper, Marianne S. Clancy, Sonia M. Thomas, Keith R. McCrae	0
4	Adeno-associated virus–based gene therapy for hemophilia A and B: a systematic review and meta-analysis 2024 ·Blood Advances ·(unknown), (unknown), Jiayi Tong, Yong Chen, Allyson M. Pishko, Adam Cuker	8
5	Contraceptive Attitudes and Beliefs of Women With Sickle Cell Disease: A Qualitative Study 2024 ·Women s Health Issues ·Andrea H. Roe, (unknown), (unknown), (unknown), (unknown), (unknown), Allyson M. Pishko, Farzana Sayani, (unknown)	1
6	Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia 2024 ·New England Journal of Medicine ·Hanny Al‐Samkari, Raj S. Kasthuri, Vivek Iyer, Allyson M. Pishko, (unknown), Clifford R. Weiss, Kevin J. Whitehead, Miles Conrad, Marc Zumberg, (unknown), Joseph G. Parambil, (unknown), Marianne S. Clancy, (unknown), L Wiśniewski, Benjamin Carper, Sonia Thomas, Keith R. McCrae	15
7	Utility of Activated Partial Thromboplastin Time Screening in Prospective Living Kidney Donors: A Single Center Cohort Study 2024 ·Kidney Medicine ·(unknown), (unknown), Eric J. Feldman, (unknown), Brian Lu, John C. Lin, Allyson M. Pishko, Robert R. Redfield, Amanda K. Leonberg‐Yoo, Adam Cuker	1
8	A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment? 2023 ·Journal of Thrombosis and Haemostasis ·Leonard A. Valentino, Margareth C. Ozelo, Roland W. Herzog, Nigel S. Key, Allyson M. Pishko, Margaret V. Ragni, Benjamin J. Samelson‐Jones, David Lillicrap	11
9	Adding caplacizumab to standard of care in thrombotic thrombocytopenic purpura: a systematic review and meta-analysis 2022 ·Blood Advances ·Mia Djulbegovic, Jiayi Tong, (unknown), Joanna C. Yang, Yong Chen, Adam Cuker, Allyson M. Pishko	16
10	Prophylactic fresh frozen plasma versus prothrombin complex concentrate for preprocedural management of the coagulopathy of liver disease: A systematic review 2022 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), Adam Cuker, Mark Crowther, Allyson M. Pishko	4
11	Cerebral Infarction due to Severe ADAMTS-13 Deficiency with Normal Hematological Parameters: A Cause of Cryptogenic Stroke 2022 ·Journal of Stroke and Cerebrovascular Diseases ·Andrew Matthews, Jennifer Yui, Elaine Y. Chiang, Allyson M. Pishko, Adam Cuker, Brett Cucchiara, Donna L. George, Farzana Sayani, Michael T. Mullen	4
12	Diagnosing heparin‐induced thrombocytopenia: The need for accuracy and speed 2021 ·International Journal of Laboratory Hematology ·Allyson M. Pishko, Adam Cuker	10
13	Bleeding risk by intensity of anticoagulation in critically ill patients with COVID‐19: A retrospective cohort study 2021 ·Journal of Thrombosis and Haemostasis ·Rim Halaby, Adam Cuker, Jennifer Yui, Andrew Matthews, (unknown), Elizabeth A. Traxler, Christopher Domenico, Tara Cooper, Ann Tierney, (unknown), (unknown), Srinath Adusumalli, Jacob T. Gutsche, Jay Giri, Steven C. Pugliese, (unknown), Allyson M. Pishko	16
14	Maximum 24‐hour platelet count fall: Metric for improving the diagnosis of heparin‐induced thrombocytopenia among patients with intermediate probability 4Ts scores 2020 ·Journal of Thrombosis and Haemostasis ·(unknown), Adam Cuker, Lori‐Ann Linkins, Theodore E. Warkentin, Allyson M. Pishko	5
15	Soluble glycoprotein VI is a predictor of major bleeding in patients with suspected heparin-induced thrombocytopenia 2020 ·Blood Advances ·Allyson M. Pishko, Robert K. Andrews, Elizabeth E. Gardiner, (unknown), Adam Cuker	11
16	The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia 2019 ·Journal of Thrombosis and Haemostasis ·Allyson M. Pishko, (unknown), Phyllis A. Gimotty, Koosha Paydary, (unknown), Gowthami M. Arepally, Mark Crowther, Lawrence Rice, (unknown), Douglas B. Cines, James P. Guevara, Adam Cuker	44
17	Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist–oncologists 2018 ·Journal of Thrombosis and Thrombolysis ·Allyson M. Pishko, Mudi Misgav, Adam Cuker, Douglas B. Cines, James N. George, Sara K. Vesely, Deirdra R. Terrell	15
18	Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia 2018 ·Blood Advances ·Allyson M. Pishko, (unknown), (unknown), Koosha Paydary, (unknown), Gowthami M. Arepally, Mark Crowther, Lawrence Rice, Douglas B. Cines, Adam Cuker	30
19	Waldenström Macroglobulinemia in Hepatitis C: Case Report and Review of the Current Literature 2014 ·Case Reports in Oncological Medicine ·Ryan David Nipp, Aaron Philip Mitchell, Allyson M. Pishko, Ara Metjian	5
20	Anticoagulation in ambulatory cancer patients with no indication for prophylactic or therapeutic anticoagulation 2012 ·Thrombosis and Haemostasis ·Allyson M. Pishko, Kenneth J. Smith, Margaret V. Ragni	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact